Ora Pharm buys Helius to become largest medical cannabis firm

Ora Pharm has acquired Helius Therapeutics, becoming New Zealand's largest medical cannabis company. The deal aims to scale up manufacturing and production for both domestic and international markets, particularly Europe.
Why it matters
The consolidation of the New Zealand cannabis sector marks a shift toward professionalization and export-oriented growth in a previously struggling industry.
Reminder, this is a Premium article and requires a subscription to read.
The article provides a factual account of a business acquisition and industry trends.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in